Report Detail
Global Preclinical Imaging Market Insights, Forecast to 2025
- RnM2753708 |
- 12 June, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Other
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
In 2018, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2018 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries.
The global Preclinical Imaging market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Preclinical Imaging market based on company, product type, end user and key regions.
This report studies the global market size of Preclinical Imaging in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Preclinical Imaging in these regions.
This research report categorizes the global Preclinical Imaging market by top players/brands, region, type and end user. This report also studies the global Preclinical Imaging market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Perkinelmer
Bruker
Fujifilm
Mediso
Milabs
MR Solutions
Aspect Imaging
Li-Cor Biosciences
Trifoil Imaging
Miltenyi Biotec
Market size by Product
Optical Imaging Systems
Nuclear Imaging Systems
Micro-MRI Systems
Micro-Ultrasound Systems
Micro-CT Systems
Preclinical Photoacoustic Imaging Systems
Preclinical Magnetic Particle Imaging (MPI) Systems
Market size by End User
Hospital
Diagnostics Center
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Preclinical Imaging market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Preclinical Imaging market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Preclinical Imaging companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Preclinical Imaging submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Preclinical Imaging are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Preclinical Imaging market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Preclinical Imaging Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Preclinical Imaging Market Size Growth Rate by Product
- 1.4.2 Optical Imaging Systems
- 1.4.3 Nuclear Imaging Systems
- 1.4.4 Micro-MRI Systems
- 1.4.5 Micro-Ultrasound Systems
- 1.4.6 Micro-CT Systems
- 1.4.7 Preclinical Photoacoustic Imaging Systems
- 1.4.8 Preclinical Magnetic Particle Imaging (MPI) Systems
- 1.5 Market by End User
- 1.5.1 Global Preclinical Imaging Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Diagnostics Center
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Preclinical Imaging Market Size
- 2.1.1 Global Preclinical Imaging Revenue 2014-2025
- 2.1.2 Global Preclinical Imaging Sales 2014-2025
- 2.2 Preclinical Imaging Growth Rate by Regions
- 2.2.1 Global Preclinical Imaging Sales by Regions
- 2.2.2 Global Preclinical Imaging Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Preclinical Imaging Sales by Manufacturers
- 3.1.1 Preclinical Imaging Sales by Manufacturers
- 3.1.2 Preclinical Imaging Sales Market Share by Manufacturers
- 3.1.3 Global Preclinical Imaging Market Concentration Ratio (CR5 and HHI)
- 3.2 Preclinical Imaging Revenue by Manufacturers
- 3.2.1 Preclinical Imaging Revenue by Manufacturers (2014-2019)
- 3.2.2 Preclinical Imaging Revenue Share by Manufacturers (2014-2019)
- 3.3 Preclinical Imaging Price by Manufacturers
- 3.4 Preclinical Imaging Manufacturing Base Distribution, Product Types
- 3.4.1 Preclinical Imaging Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Preclinical Imaging Product Type
- 3.4.3 Date of International Manufacturers Enter into Preclinical Imaging Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Preclinical Imaging Sales by Product
- 4.2 Global Preclinical Imaging Revenue by Product
- 4.3 Preclinical Imaging Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Preclinical Imaging Breakdown Data by End User
6 North America
- 6.1 North America Preclinical Imaging by Countries
- 6.1.1 North America Preclinical Imaging Sales by Countries
- 6.1.2 North America Preclinical Imaging Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Preclinical Imaging by Product
- 6.3 North America Preclinical Imaging by End User
7 Europe
- 7.1 Europe Preclinical Imaging by Countries
- 7.1.1 Europe Preclinical Imaging Sales by Countries
- 7.1.2 Europe Preclinical Imaging Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Preclinical Imaging by Product
- 7.3 Europe Preclinical Imaging by End User
8 Asia Pacific
- 8.1 Asia Pacific Preclinical Imaging by Countries
- 8.1.1 Asia Pacific Preclinical Imaging Sales by Countries
- 8.1.2 Asia Pacific Preclinical Imaging Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Preclinical Imaging by Product
- 8.3 Asia Pacific Preclinical Imaging by End User
9 Central & South America
- 9.1 Central & South America Preclinical Imaging by Countries
- 9.1.1 Central & South America Preclinical Imaging Sales by Countries
- 9.1.2 Central & South America Preclinical Imaging Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Preclinical Imaging by Product
- 9.3 Central & South America Preclinical Imaging by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Preclinical Imaging by Countries
- 10.1.1 Middle East and Africa Preclinical Imaging Sales by Countries
- 10.1.2 Middle East and Africa Preclinical Imaging Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Preclinical Imaging by Product
- 10.3 Middle East and Africa Preclinical Imaging by End User
11 Company Profiles
- 11.1 Perkinelmer
- 11.1.1 Perkinelmer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Perkinelmer Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Perkinelmer Preclinical Imaging Products Offered
- 11.1.5 Perkinelmer Recent Development
- 11.2 Bruker
- 11.2.1 Bruker Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bruker Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bruker Preclinical Imaging Products Offered
- 11.2.5 Bruker Recent Development
- 11.3 Fujifilm
- 11.3.1 Fujifilm Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Fujifilm Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Fujifilm Preclinical Imaging Products Offered
- 11.3.5 Fujifilm Recent Development
- 11.4 Mediso
- 11.4.1 Mediso Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Mediso Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Mediso Preclinical Imaging Products Offered
- 11.4.5 Mediso Recent Development
- 11.5 Milabs
- 11.5.1 Milabs Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Milabs Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Milabs Preclinical Imaging Products Offered
- 11.5.5 Milabs Recent Development
- 11.6 MR Solutions
- 11.6.1 MR Solutions Company Details
- 11.6.2 Company Business Overview
- 11.6.3 MR Solutions Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 MR Solutions Preclinical Imaging Products Offered
- 11.6.5 MR Solutions Recent Development
- 11.7 Aspect Imaging
- 11.7.1 Aspect Imaging Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Aspect Imaging Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Aspect Imaging Preclinical Imaging Products Offered
- 11.7.5 Aspect Imaging Recent Development
- 11.8 Li-Cor Biosciences
- 11.8.1 Li-Cor Biosciences Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Li-Cor Biosciences Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Li-Cor Biosciences Preclinical Imaging Products Offered
- 11.8.5 Li-Cor Biosciences Recent Development
- 11.9 Trifoil Imaging
- 11.9.1 Trifoil Imaging Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Trifoil Imaging Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Trifoil Imaging Preclinical Imaging Products Offered
- 11.9.5 Trifoil Imaging Recent Development
- 11.10 Miltenyi Biotec
- 11.10.1 Miltenyi Biotec Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Miltenyi Biotec Preclinical Imaging Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Miltenyi Biotec Preclinical Imaging Products Offered
- 11.10.5 Miltenyi Biotec Recent Development
12 Future Forecast
- 12.1 Preclinical Imaging Market Forecast by Regions
- 12.1.1 Global Preclinical Imaging Sales Forecast by Regions 2019-2025
- 12.1.2 Global Preclinical Imaging Revenue Forecast by Regions 2019-2025
- 12.2 Preclinical Imaging Market Forecast by Product
- 12.2.1 Global Preclinical Imaging Sales Forecast by Product 2019-2025
- 12.2.2 Global Preclinical Imaging Revenue Forecast by Product 2019-2025
- 12.3 Preclinical Imaging Market Forecast by End User
- 12.4 North America Preclinical Imaging Forecast
- 12.5 Europe Preclinical Imaging Forecast
- 12.6 Asia Pacific Preclinical Imaging Forecast
- 12.7 Central & South America Preclinical Imaging Forecast
- 12.8 Middle East and Africa Preclinical Imaging Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Preclinical Imaging Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Preclinical Imaging . Industry analysis & Market Report on Preclinical Imaging is a syndicated market report, published as Global Preclinical Imaging Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Preclinical Imaging market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
